Cargando…

Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options

Ovarian cancer is the leading cause of gynecological cancer death. Improved understanding of the biologic pathways and introduction of poly (ADP-ribose) polymerase inhibitors (PARPi) during the last decade have changed the treatment landscape. This has improved outcomes, but unfortunately half the w...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Vikas, Oza, Amit M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581945/
https://www.ncbi.nlm.nih.gov/pubmed/37737434
http://dx.doi.org/10.1007/s40265-023-01934-0